The suite of currently used drugs can be divided into two categories–traditional 'small
molecule'drugs with typical molecular weights of< 500 Da but with oral bioavailability, and …

Peptides as ‘Drugs’: The Journey so Far | SpringerLink Skip to main content Advertisement
SpringerLink Log in Menu Find a journal Publish with us Search Cart 1.Home 2.International …

Highlights•We provide a SWOT analysis of peptide therapeutics and discuss commercial
aspects.•We comment on emerging peptide technologies and cell-penetrating peptides.• …

The decreasing number of approved drugs produced by the pharmaceutical industry, which
has been accompanied by increasing expenses for R&D, demands alternative approaches …

Over the past decade, peptide drug discovery has experienced a revival of interest and
scientific momentum, as the pharmaceutical industry has come to appreciate the role that …

Peptide drug development has made great progress in the last decade thanks to new
production, modification, and analytic technologies. Peptides have been produced and …

Peptide Therapeutics 2.0 Page 1 molecules Editorial Peptide Therapeutics 2.0 Beatriz G. de la
Torre 1,* and Fernando Albericio 2,3,4,* 1 KwaZulu-Natal Research Innovation and …

After many years of stagnation, peptide therapeutics once again became the focus of
innovative drug development efforts backed up by venture funds and biotechnology …

The analysis of these peptides by therapeutic categories is an indication of the versatility of
peptides to tackle a large number of biochemical transgressions. Thus, boceprevir and …

The first synthetic peptide was prepared by Emil Fischer a century ago, but the medicinal
use of synthetic peptides started after the Second World War, and only when peptides could …